| RS2539306378 |
MARK2
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2539312069 |
A2ML1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2539312217 |
CAPN1
|
Health Risk |
Likely pathogenic |
CAPN1-related disorder, CAPN1-related disorder |
| RS2539312667 |
CAPN1
|
Health Risk |
Pathogenic |
— |
| RS2539313698 |
MARK2
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Intellectual developmental disorder |
| RS2539314305 |
CLPB
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria, type VIIB |
| RS2539315343 |
MARK2
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Intellectual developmental disorder |
| RS2539316753 |
CLPB
|
Health Risk |
Likely pathogenic |
3-methylglutaconic aciduria, type VIIB |
| RS2539319606 |
MARK2
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2539321295 |
MARK2
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Intellectual developmental disorder |
| RS2539322573 |
MARK2
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Malignant tumor of urinary bladder |
| RS2539323563 |
CLPB
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria, type VIIB |
| RS2539326870 |
MARK2
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2539328377 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS2539330444 |
MARK2
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2539332826 |
MARK2
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2539333959 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2539334508 |
FKTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2M, Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability) |
| RS2539334846 |
FKTN
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2539335503 |
MARK2
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2539336006 |
MARK2
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, MARK2-associated neurodevelopmental disorder |
| RS2539337600 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2539338375 |
FKTN
|
Health Risk |
Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2539338637 |
CACNA1B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2539340597 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS2539345095 |
CACNA1B
|
Health Risk |
Likely pathogenic |
— |
| RS2539345198 |
CACNA1B
|
Health Risk |
Likely pathogenic |
— |
| RS2539346486 |
CLPB
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2539350226 |
MARK2
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Intellectual developmental disorder |
| RS2539350467 |
MARK2
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Intellectual developmental disorder |
| RS2539350478 |
BMPR1A
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2539350502 |
MARK2
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2539350612 |
MARK2
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2539351000 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS2539351347 |
BMPR1A
|
Health Risk |
Likely pathogenic |
Juvenile polyposis syndrome, Colorectal cancer |
| RS2539363727 |
POMT1
|
Health Risk |
Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2539364366 |
POMT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS2539365192 |
CTR9
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2539366355 |
POMT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS2539366540 |
FGF8
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2539366599 |
CTR9
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2539366637 |
CTR9
|
Health Risk |
Likely pathogenic |
— |
| RS2539366660 |
CTR9
|
Health Risk |
Likely pathogenic |
— |
| RS2539372922 |
CACNA1B
|
Health Risk |
Pathogenic |
— |
| RS2539373332 |
CACNA1B
|
Health Risk |
Pathogenic |
— |
| RS2539375126 |
CACNA1B
|
Health Risk |
Pathogenic |
— |
| RS2539376880 |
TRAPPC9
|
Health Risk |
Likely pathogenic |
— |
| RS2539378110 |
POMT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS2539378745 |
TRAPPC9
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 13 |
| RS2539378902 |
TRAPPC9
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 13 |
| RS2539380198 |
CTR9
|
Health Risk |
Likely pathogenic |
— |
| RS2539381136 |
POMT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS2539396830 |
LRSAM1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS2539397796 |
POMT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS2539402070 |
FKTN
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2539402514 |
FKTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2M, Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability) |
| RS2539403350 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Autosomal recessive limb-girdle muscular dystrophy type 2M |
| RS2539404585 |
FKTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2M, Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability) |
| RS2539404849 |
FKTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2M, Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability) |
| RS2539405255 |
FKTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2M, Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability) |
| RS2539406491 |
FKTN
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2539406905 |
FKTN
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2539407411 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539409368 |
COQ4
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome, Inborn genetic diseases |
| RS2539409439 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2539410162 |
COQ4
|
Health Risk |
Pathogenic |
Spastic ataxia 10, autosomal recessive |
| RS2539410522 |
RDX
|
Health Risk |
Pathogenic |
— |
| RS2539411480 |
FKTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2M, Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability) |
| RS2539412353 |
FKTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2M, Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability) |
| RS2539412643 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2539413215 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2539414037 |
FKTN
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2539414072 |
FKTN
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2539414638 |
RDX
|
Health Risk |
Pathogenic |
— |
| RS2539415192 |
COQ4
|
Health Risk |
Likely pathogenic |
Developmental disorder, Developmental disorder |
| RS2539417930 |
CACNA1B
|
Health Risk |
Pathogenic |
— |
| RS2539418643 |
POMT1
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2539419195 |
FGFR2
|
Health Risk |
Likely pathogenic |
Pfeiffer syndrome, Pfeiffer syndrome |
| RS2539423213 |
RDX
|
Health Risk |
Pathogenic |
— |
| RS2539429929 |
BMPR1A
|
Health Risk |
Likely pathogenic |
Polyposis syndrome, hereditary mixed |
| RS2539430767 |
BMPR1A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS2539431082 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539431097 |
BMPR1A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS2539431847 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539432372 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539432575 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539433562 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS2539441210 |
RDX
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 24, Autosomal recessive nonsyndromic hearing loss 24 |
| RS2539442673 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS2539442748 |
LRSAM1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS2539445569 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539446205 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539446223 |
BMPR1A
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2539447975 |
CACNA1B
|
Health Risk |
Likely pathogenic |
CACNA1B-related disorder, CACNA1B-related disorder |
| RS2539451092 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS2539452586 |
POMT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS2539453407 |
POMT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS2539454813 |
POMT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS2539455086 |
POMT1
|
Health Risk |
Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2K |
| RS2539457972 |
SLC27A4
|
Health Risk |
Likely pathogenic |
Ichthyosis prematurity syndrome, Ichthyosis prematurity syndrome |